| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $3,515,736 | 9 | 69 |
Sells | $11,715,314 | 4 | 31 |
| Hughes Owen | Chief Executive Officer | 1 | $2.5M | 1 | $650,667 | $1.85M |
| LIMBER JOSEPH M | director | 3 | $760,145 | 0 | $0 | $760,145 |
| Sitko Bradley | Chief Investment Officer | 4 | $225,132 | 0 | $0 | $225,132 |
| BURNS THOMAS M. | SVP, Finance & CFO | 1 | $25,460 | 2 | $421,853 | $-396,393 |
| BVF PARTNERS L P/IL | 10 percent owner | 0 | $0 | 1 | $10.64M | $-10.64M |
XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Over the last 12 months, insiders at XOMA Royalty Corp. have bought $3.52M and sold $11.72M worth of XOMA Royalty Corp. stock.
On average, over the past 5 years, insiders at XOMA Royalty Corp. have bought $1.14M and sold $9.5M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hughes Owen (Chief Executive Officer) — $2.5M. LIMBER JOSEPH M (director) — $760,145. Sitko Bradley (Chief Investment Officer) — $225,132.
The last purchase of 100,000 shares for transaction amount of $2.5M was made by Hughes Owen (Chief Executive Officer) on 2025‑12‑04.
| 2025-12-04 | Hughes Owen | Chief Executive Officer | 100,000 0.6708% | $25.05 | $2.5M | -16.05% | ||
| 2025-09-22 | Sale | BURNS THOMAS M. | SVP, Finance & CFO | 4,330 0.0353% | $35.99 | $155,820 | -19.79% | |
| 2025-06-30 | Sitko Bradley | Chief Investment Officer | 2,000 0.0168% | $25.39 | $50,780 | +17.30% | ||
| 2025-05-20 | Sale | Hughes Owen | Chief Executive Officer | 25,637 0.2044% | $25.38 | $650,667 | +2.52% | |
| 2025-05-20 | Sale | BURNS THOMAS M. | SVP, Finance & CFO | 10,482 0.0836% | $25.38 | $266,033 | +2.52% | |
| 2025-05-16 | Sale | BVF PARTNERS L P/IL | 10 percent owner | 392,723 3.2951% | $27.10 | $10.64M | +1.04% | |
| 2025-04-07 | LIMBER JOSEPH M | director | 5,243 – | $25.60 | $134,221 | +39.31% | ||
| 2025-04-07 | Sitko Bradley | Chief Investment Officer | 2,000 0.0214% | $24.70 | $49,400 | +39.31% | ||
| 2025-04-04 | LIMBER JOSEPH M | director | 6,822 – | $25.40 | $173,293 | +37.68% | ||
| 2025-04-03 | LIMBER JOSEPH M | director | 17,935 – | $25.24 | $452,631 | +34.98% | ||
| 2025-04-01 | BURNS THOMAS M. | SVP, Finance & CFO | 1,000 0.011% | $25.46 | $25,460 | +38.46% | ||
| 2025-03-31 | Sitko Bradley | Chief Investment Officer | 1,245 – | $21.04 | $26,201 | +34.03% | ||
| 2025-03-21 | Sitko Bradley | Chief Investment Officer | 4,134 0.0395% | $23.89 | $98,751 | +27.42% | ||
| 2025-01-24 | Sale | BVF PARTNERS L P/IL | 10 percent owner | 575,430 4.8136% | $26.10 | $15.02M | -0.75% | |
| 2025-01-08 | Sitko Bradley | Chief Investment Officer | 545 0.0046% | $25.64 | $13,975 | +2.86% | ||
| 2024-12-31 | Sitko Bradley | Chief Investment Officer | 300 0.0025% | $25.90 | $7,770 | +0.38% | ||
| 2024-11-13 | Sale | Hughes Owen | Chief Executive Officer | 21,881 0.1841% | $29.95 | $655,336 | -10.45% | |
| 2024-11-13 | Sale | BURNS THOMAS M. | SVP, Finance & CFO | 9,775 0.0822% | $29.94 | $292,664 | -10.45% | |
| 2023-10-03 | Sitko Bradley | Chief Investment Officer | 250 0.0022% | $13.89 | $3,473 | +77.06% | ||
| 2023-10-02 | Sitko Bradley | Chief Investment Officer | 1,500 0.0133% | $14.25 | $21,375 | +74.14% |
| BVF PARTNERS L P/IL | 10 percent owner | 1267545 10.2361% | $32.93M | 48 | 2 | +31.12% |
| Hughes Owen | Chief Executive Officer | 102000 0.8237% | $2.65M | 6 | 2 | +41.21% |
| BURNS THOMAS M. | SVP, Finance & CFO | 30079 0.2429% | $781,452.42 | 1 | 18 | |
| LIMBER JOSEPH M | director | 10000 0.0808% | $259,800.00 | 3 | 0 | |
| Sitko Bradley | Chief Investment Officer | 7045 0.0569% | $183,029.10 | 14 | 0 | +11.58% |
| BAKER JULIAN | director | 17888512 144.459% | $464.74M | 1 | 0 | +27.37% |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 326601 2.6375% | $8.49M | 0 | 32 | |
| PERRY MATTHEW D | See Explanation of Responses | 200000 1.6151% | $5.2M | 1 | 0 | <0.0001% |
| DELLIO CLARENCE L | Sr VP, Operations and COO | 101456 0.8193% | $2.64M | 0 | 4 | |
| DAVIS PETER B | VP, Finance & CFO | 94960 0.7669% | $2.47M | 1 | 0 | <0.0001% |
| BAKER BROS. ADVISORS LP | other | 90538 0.7311% | $2.35M | 1 | 17 | +28.45% |
| KURLAND FRED | CFO & VP Finance | 85086 0.6871% | $2.21M | 1 | 6 | <0.0001% |
| MARGOLIN CHRISTOPHER J | VP, General Counsel & Sec'y | 55687 0.4497% | $1.45M | 0 | 2 | |
| Klein Thomas | Chief Commercial Officer | 43858 0.3542% | $1.14M | 0 | 1 | |
| MENDELL STEVEN C | director | 40000 0.323% | $1.04M | 0 | 1 | |
| Neal James R | CEO | 15939 0.1287% | $414,095.22 | 3 | 26 | +31.48% |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 8217 0.0664% | $213,477.66 | 0 | 26 | |
| BOYLE J DAVID II | VP, Finance, and CFO | 5000 0.0404% | $129,900.00 | 1 | 0 | +21.99% |
| Varian John | director | 2344 0.0189% | $60,897.12 | 0 | 34 | |
| ANDRESS JAMES G | director | 2000 0.0162% | $51,960.00 | 1 | 0 | <0.0001% |
| VAN NESS W DENMAN | director | 0 0% | $0 | 0 | 4 |
$26,922,905 | 100 | 5.55% | $297.62M | |
$5,960,789 | 91 | -7.17% | $319.9M | |
XOMA Corporation (XOMA) | $69,151,774 | 71 | 24.96% | $321.71M |
$24,384,691 | 42 | -30.27% | $312.43M | |
$16,169,789 | 40 | 7.44% | $332.61M | |
$64,487,106 | 32 | -22.92% | $311.97M | |
$54,828,550 | 26 | -13.88% | $340.21M | |
$1,842,003 | 22 | -0.74% | $326.33M | |
$65,355,913 | 13 | -3.42% | $355.62M | |
$10,143,329 | 12 | 11.84% | $314.35M | |
$81,667,942 | 12 | -57.54% | $357.88M | |
$603,645 | 8 | 57.40% | $360.27M | |
$13,043,783 | 8 | 732.82% | $305.16M | |
$1,346,998 | 7 | 25.06% | $297.64M | |
$17,675,244 | 7 | 92.20% | $307.8M | |
$2,720,023 | 3 | -11.76% | $343.41M | |
$4,888,000 | 3 | -20.50% | $338.6M | |
$1,516,110 | 3 | 8.05% | $294.27M | |
$20,020,000 | 1 | -75.24% | $354.71M |
| Increased Positions | 48 | +44.44% | 2M | +13.42% |
| Decreased Positions | 42 | -38.89% | 2M | -13.41% |
| New Positions | 18 | New | 975,443 | New |
| Sold Out Positions | 14 | Sold Out | 773,630 | Sold Out |
| Total Postitions | 114 | +5.56% | 13M | +<0.01% |
| Bvf Inc/Il | $72,503.00 | 21.59% | 2.59M | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $46,099.00 | 13.73% | 1.65M | -72,877 | -4.24% | 2025-09-30 |
| Fmr Llc | $30,070.00 | 8.95% | 1.07M | -1M | -51.89% | 2025-09-30 |
| Vanguard Group Inc | $18,700.00 | 5.57% | 668,111 | -2M | -69.27% | 2025-09-30 |
| Blackrock, Inc. | $16,595.00 | 4.94% | 592,902 | -387,370 | -39.52% | 2025-09-30 |
| Opaleye Management Inc. | $7,140.00 | 2.13% | 255,087 | 0 | 0% | 2025-09-30 |
| Xtx Topco Ltd | $6,146.00 | 1.83% | 219,585 | +139,046 | +172.64% | 2025-09-30 |
| Geode Capital Management, Llc | $5,933.00 | 1.77% | 211,977 | -376,955 | -64.01% | 2025-09-30 |
| Woodline Partners Lp | $5,876.00 | 1.75% | 209,945 | +29,715 | +16.49% | 2025-09-30 |
| State Street Corp | $4,675.00 | 1.39% | 167,035 | -96,712 | -36.67% | 2025-09-30 |